Literature DB >> 10869496

Hypertolerance to morphine in G(z alpha)-deficient mice.

I A Hendry1, K L Kelleher, S E Bartlett, K J Leck, A J Reynolds, K Heydon, A Mellick, D Megirian, K I Matthaei.   

Abstract

Our laboratory has generated a mouse deficient in the alpha (alpha) subunit of the G protein, G(z), (G(z alpha)) gene and we have examined the involvement of G(z alpha) in spinal and supraspinal analgesia and tolerance mechanisms. Spinal analgesia was tested by the response times to heat or cold tail flick times in a water bath at 50 degrees C or -5 degrees C and supraspinal analgesia was tested by the times for paw licking and jumping from a plate at 52 degrees C or 0.5 degrees C. Tolerance to morphine was induced in wild type and G(z alpha)-deficient mice over a 5 day period and the behavioral tests were performed daily. The tail flick reaction times to both hot and cold stimuli did not differ between the wild type and G(z alpha)-deficient mice. Analysis of the reaction times from the hot and cold plate tests showed the G(z alpha)-deficient mice developed tolerance to morphine to a greater degree and at a faster rate than wild type mice. Opioid binding assays were performed on synaptic membranes prepared from naive and morphine tolerant wild type and G(z alpha)-deficient brains. No changes in the affinity of morphine for its receptor or in the density of mu and delta opioid receptors were found between the two groups of mice in the naive or morphine tolerant state. This indicates that the absence of G(z alpha) does not affect opioid receptor affinity or receptor up or down regulation. Our results suggest that the presence of G(z alpha) delays the development of morphine tolerance and represents a possible therapeutic target for improving the clinical use of morphine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869496     DOI: 10.1016/s0006-8993(00)02387-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs.

Authors:  J Yang; J Wu; M A Kowalska; A Dalvi; N Prevost; P J O'Brien; D Manning; M Poncz; I Lucki; J A Blendy; L F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

2.  High incidence of recurrent copy number variants in patients with isolated and syndromic Müllerian aplasia.

Authors:  Serena Nik-Zainal; Reiner Strick; Mekayla Storer; Ni Huang; Roland Rad; Lionel Willatt; Tomas Fitzgerald; Vicki Martin; Richard Sandford; Nigel P Carter; Andreas R Janecke; Stefan P Renner; Patricia G Oppelt; Peter Oppelt; Christine Schulze; Sara Brucker; Matthew Hurles; Matthias W Beckmann; Pamela L Strissel; Charles Shaw-Smith
Journal:  J Med Genet       Date:  2011-01-28       Impact factor: 6.318

Review 3.  Candidate gene polymorphisms predicting individual sensitivity to opioids.

Authors:  Shinya Kasai; Masakazu Hayashida; Ichiro Sora; Kazutaka Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

4.  μ-Opioid receptor coupling to Gα(o) plays an important role in opioid antinociception.

Authors:  Jennifer T Lamberts; Emily M Jutkiewicz; Richard M Mortensen; John R Traynor
Journal:  Neuropsychopharmacology       Date:  2011-06-08       Impact factor: 7.853

5.  Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.

Authors:  Sevasti Gaspari; Immanuel Purushothaman; Valeria Cogliani; Farhana Sakloth; Rachael L Neve; David Howland; Robert H Ring; Elliott M Ross; Li Shen; Venetia Zachariou
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

6.  Deletion of GαZ protein protects against diet-induced glucose intolerance via expansion of β-cell mass.

Authors:  Michelle E Kimple; Jennifer B Moss; Harpreet K Brar; Taylor C Rosa; Nathan A Truchan; Renee L Pasker; Christopher B Newgard; Patrick J Casey
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

7.  Gαz regulates BDNF-induction of axon growth in cortical neurons.

Authors:  Rainbo Hultman; Udhaya Kumari; Nadine Michel; Patrick J Casey
Journal:  Mol Cell Neurosci       Date:  2013-12-07       Impact factor: 4.314

8.  Essential role for RGS9 in opiate action.

Authors:  Venetia Zachariou; Dan Georgescu; Nick Sanchez; Zia Rahman; Ralph DiLeone; Olivier Berton; Rachael L Neve; Laura J Sim-Selley; Dana E Selley; Stephen J Gold; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

9.  Rapid and pervasive changes in genome-wide enhancer usage during mammalian development.

Authors:  Alex S Nord; Matthew J Blow; Catia Attanasio; Jennifer A Akiyama; Amy Holt; Roya Hosseini; Sengthavy Phouanenavong; Ingrid Plajzer-Frick; Malak Shoukry; Veena Afzal; John L R Rubenstein; Edward M Rubin; Len A Pennacchio; Axel Visel
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

10.  Analysis of candidate genes for morphine preference quantitative trait locus Mop2.

Authors:  G A Doyle; C L Schwebel; S E Ruiz; A D Chou; A T Lai; M-J Wang; G G Smith; R J Buono; W H Berrettini; T N Ferraro
Journal:  Neuroscience       Date:  2014-07-22       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.